Publications

Export 8 results:
Auteur Title [ Type(Desc)] Année
Filtres: Auteur is Kiessling, Silke  [Enlever les filtres]
Journal Article
Reynolds LM, Makowski CS, Yogendran SV, Kiessling S, Cermakian N, Flores C.  2015.  Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner.. Neuropsychopharmacology. 40(5):1101-12.
Kiessling S, Dubeau-Laramée G, Ohm H, Labrecque N, Olivier M, Cermakian N.  2017.  The circadian clock in immune cells controls the magnitude of Leishmania parasite infection.. Sci Rep. 7(1):10892.
Cermakian N, Westfall S, Kiessling S.  2014.  Circadian clocks and inflammation: reciprocal regulation and shared mediators.. Arch Immunol Ther Exp (Warsz). 62(4):303-18.
Bhardwaj SK, Stojkovic K, Kiessling S, Srivastava LK, Cermakian N.  2015.  Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.. Behav Brain Res. 284:58-68.
Kiessling S, Beaulieu-Laroche L, Blum ID, Landgraf D, Welsh DK, Storch K-F, Labrecque N, Cermakian N.  2017.  Enhancing circadian clock function in cancer cells inhibits tumor growth.. BMC Biol. 15(1):13.
Landgraf D, Joiner WJ, McCarthy MJ, Kiessling S, Barandas R, Young JW, Cermakian N, Welsh DK.  2016.  The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms.. Neuropharmacology. 107:262-70.
Uetani N, Hardy S, Gravel S-P, Kiessling S, Pietrobon A, Wong NNau, Chénard V, Cermakian N, St-Pierre J, Tremblay ML.  2017.  PRL2 links magnesium flux and sex-dependent circadian metabolic rhythms.. JCI Insight. 2(13)
Kiessling S, Cermakian N.  2017.  The tumor circadian clock: a new target for cancer therapy? Future Oncol. 13(29):2607-2610.

  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre